---
schema_version: "secwatch.filing_event.v1"
accession: "0001823239-21-000023"
form_type: "8-K"
ticker: "MRVI"
cik: "0001823239"
company_name: "MARAVAI LIFESCIENCES HOLDINGS, INC."
filed_at: "2021-09-03T23:59:59+00:00"
generated_at: "2026-06-29T05:53:59.186175+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Maravai closes sale of Protein Detection segment; amends Pfizer/BioNTech supply pact

## Summary
- Closed sale of Vector Laboratories (Protein Detection) to Voyager Group/Thompson Street on Sept 2, 2021.
- Disposition not considered a significant business; Vector CEO Lisa Sellers leaves Maravai.
- Amendment to TriLink supply agreement with Pfizer and BioNTech shifts invoicing to shipment-based from milestone-based.
- Amendment effective June 6, 2021; redacted pricing/billing terms included.
- Deal amendments clarify payments for facility relocation and exclude certain payables from purchase price adjustments.

## SEC filing metadata
- accession: 0001823239-21-000023
- form_type: 8-K
- ticker: MRVI
- cik: 0001823239
- company_name: MARAVAI LIFESCIENCES HOLDINGS, INC.
- filed_at: 2021-09-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1823239/000182323921000023/0001823239-21-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1823239/000182323921000023/mrvi-20210902.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001823239-21-000023
- JSON: https://secwatch.observer/filing/0001823239-21-000023.json
- Plain text: https://secwatch.observer/filing/0001823239-21-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.